A Gucalp, TA Traina, JR Eisner, JS Parker… - Breast cancer research …, 2019 - Springer
Purpose Male breast cancer (BC) is rare, representing approximately 1% of cancers that occur in men and approximately 1% of all BCs worldwide. Because male BC is rare, not …
C Yau, M Osdoit, M van der Noordaa, S Shad… - The Lancet …, 2022 - thelancet.com
Background Previous studies have independently validated the prognostic relevance of residual cancer burden (RCB) after neoadjuvant chemotherapy. We used results from …
Metastasis is the major driver of death in patients with cancer. Invasion of surrounding tissues and metastasis have been proposed to initiate following loss of the intercellular …
Invasive lobular carcinoma (ILC) demonstrates lower conspicuity on 18F-FDG PET than the more common invasive ductal carcinoma. Other molecular imaging methods may be needed …
WA Berg, L Gutierrez, MS NessAiver, WB Carter… - radiology, 2004 - pubs.rsna.org
PURPOSE: To prospectively assess accuracy of mammography, clinical examination, ultrasonography (US), and magnetic resonance (MR) imaging in preoperative assessment …
A Bombonati, DC Sgroi - The Journal of pathology, 2011 - Wiley Online Library
The current model of human breast cancer progression proposes a linear multi‐step process which initiates as flat epithelial atypia (FEA), progresses to atypical ductal hyperplasia …
Epithelial–mesenchymal transition (EMT) is a program wherein epithelial cells lose their junctions and polarity while acquiring mesenchymal properties and invasive ability …
In women,∼ 10% of cancers occur in those< 45 years old. Chemotherapy, radiotherapy and bone marrow transplantation can cure> 90% of girls and young women with diseases that …
JA Mouabbi, A Hassan, B Lim, GN Hortobagyi… - Breast cancer research …, 2022 - Springer
Invasive lobular carcinoma (ILC) is the second most common histologic subtype of breast cancer after invasive ductal carcinoma (IDC), accounting for 10–15% of all breast cancer …